February 24, 2009 - Basilea Pharmaceutica Ltd. announces that the EU Committee for Medicinal Products for Human Use has indicated that the European Commission decision process on Zevtera (ceftobiprole) for the treatment of complicated skin and soft tissue infections is delayed.
the details can be read here.
No comments:
Post a Comment